These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7010681)
1. Indomethacin inhibits the antihypertensive effect of captopril, SQ 14225, in low renin hypertension. Abe K; Itoh T; Imai Y; Sato M; Goto T; Otsuka Y; Yoshinaga K Tohoku J Exp Med; 1980 Sep; 132(1):117-8. PubMed ID: 7010681 [TBL] [Abstract][Full Text] [Related]
2. Implication of endogenous prostaglandin system in the antihypertensive effect of captopril, SQ 14225, in low renin hypertension. Abe K; Itoh T; Imai Y; Sato M; Haruyama T; Sakurai Y; Goto T; Otsuka Y; Yoshinaga K Jpn Circ J; 1980 May; 44(5):422-5. PubMed ID: 6993721 [TBL] [Abstract][Full Text] [Related]
3. Role of prostaglandin in the antihypertensive mechanism of captopril in low renin hypertension. Abe K; Ito T; Sato M; Haruyama T; Sato K; Omata K; Hiwatari M; Sakurai Y; Imai Y; Yoshinaga K Clin Sci (Lond); 1980 Dec; 59 Suppl 6():141s-144s. PubMed ID: 7004721 [TBL] [Abstract][Full Text] [Related]
4. Single-dose captopril administration in DOCA/salt rats: reduction of hypotensive effect by indomethacin. Miyamori I; Brown MJ; Dollery CT Clin Exp Hypertens (1978); 1980; 2(6):935-45. PubMed ID: 7004806 [TBL] [Abstract][Full Text] [Related]
5. Indomethacin (IND) inhibits an enhanced renin release following the captopril, SQ 14225, administration. Abe K; Itoh T; Satoh M; Haruyama T; Imai Y; Goto T; Satoh K; Otsuka Y; Yoshinaga K Life Sci; 1980 Feb; 26(7):561-5. PubMed ID: 6988657 [No Abstract] [Full Text] [Related]
6. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels. Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579 [TBL] [Abstract][Full Text] [Related]
7. Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition. Silberbauer K; Stanek B; Templ H Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):87S-93S. PubMed ID: 6753910 [TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects. Ueda Y; Honda M; Hatano M Jpn Circ J; 1982 Mar; 46(3):267-73. PubMed ID: 6278173 [TBL] [Abstract][Full Text] [Related]
9. Effect of indomethacin on antihypertensive action of captopril in hypertensive patients. Fujita T; Yamashita N; Yamashita K Clin Exp Hypertens (1978); 1981; 3(5):939-52. PubMed ID: 7026199 [TBL] [Abstract][Full Text] [Related]
10. Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension. Moore TJ; Crantz FR; Hollenberg NK; Koletsky RJ; Leboff MS; Swartz SL; Levine L; Podolsky S; Dluhy RG; Williams GH Hypertension; 1981; 3(2):168-73. PubMed ID: 6260645 [TBL] [Abstract][Full Text] [Related]
11. [Renin and aldosterone secretion under converting enzyme inhibition]. Nakamura K Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1099-116. PubMed ID: 6141075 [TBL] [Abstract][Full Text] [Related]
12. Indomethacin does not attenuate the hypotensive effect of captopril, a converting enzyme inhibitor in Goldblatt hypertensive rats. Omata K; Otsuka Y; Chiba S; Itoh T; Gotoh T; Imai Y; Sakurai Y; Satoh M; Haruyama T; Hiwatari M; Satoh K; Kaitoh A; Abe K; Yoshinaga K Tohoku J Exp Med; 1981 May; 134(1):9-19. PubMed ID: 7031986 [No Abstract] [Full Text] [Related]
14. Evidence for a dual action of converting enzyme inhibitor on blood pressure in normal man. Goldstone R; Martin K; Zipser R; Horton R Prostaglandins; 1981 Oct; 22(4):587-98. PubMed ID: 6275456 [TBL] [Abstract][Full Text] [Related]
15. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity. Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756 [TBL] [Abstract][Full Text] [Related]
16. Differences in response to the peptidyldipeptide hydrolase inhibitors SQ 20,881 and SQ 14,225 in normal-renin essential hypertension. Crantz FR; Swartz SL; Hollenberg NK; Moore TJ; Dluhy RG; Williams GH Hypertension; 1980; 2(5):604-9. PubMed ID: 6158478 [TBL] [Abstract][Full Text] [Related]
17. Acute haemodynamic and hormonal effects of captopril are diminished by indomethacin. Witzgall H; Hirsch F; Scherer B; Weber PC Clin Sci (Lond); 1982 Jun; 62(6):611-5. PubMed ID: 7044652 [TBL] [Abstract][Full Text] [Related]
18. [Antihypertensive mechanism of oral angiotensin I converting enzyme inhibitor (captopril) in renin-independent essential hypertension]. Miyamori I; Takeda Y; Ikeda M; Koshida H; Yasuhara S; Morise T; Takimoto H; Takeda R; Nishino T Nihon Naibunpi Gakkai Zasshi; 1983 Jun; 59(6):907-17. PubMed ID: 6311635 [TBL] [Abstract][Full Text] [Related]
19. Exaggerated response of renin secretion to captopril (SQ 14225) in renovascular hypertension. Imai Y; Abe K; Otsuka Y; Sakurai Y; Ito T; Sato M; Haruyama T; Omata K; Hiwatari M; Yoshinaga K Jpn Heart J; 1980 Nov; 21(6):793-802. PubMed ID: 7007685 [TBL] [Abstract][Full Text] [Related]
20. Reduction of the antihypertensive effect of captopril induced by prostaglandin synthetase inhibition. Covi G; Minuz P; Capuzzo G; Lechi C; Delva P; Lechi A Int J Clin Pharmacol Res; 1984; 4(1):47-52. PubMed ID: 6432714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]